Can kids quit their eczema shots? new trial aims to find out
NCT ID NCT06116526
Summary
This study is testing whether children with well-controlled eczema can safely reduce the dose or completely stop their dupilumab injections. Researchers at Johns Hopkins will randomly assign 30 children, aged 1 to 17, to either continue their standard dose, take a lower dose, or stop the medication entirely. The goal is to see if controlling eczema with less medicine is possible and sustainable over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins Univerisity
RECRUITINGBaltimore, Maryland, 21210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.